A meta-analysis and systematic review19 evaluating the efficacy of hydroxychloroquine (HCQ) in treating primary Sjögren syndrome found significant improvements in oral symptoms, unstimulated salivary flow rate (uSFR), the inflammatory indicators include ESR and C-reactive protein CRP plus immunoglobulin IgM levels. This evidence concerns the gene CD40LG and Sjogren syndrome.